Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder
Sponsor: Boston University
Listed as NCT02066792, this EARLY_PHASE1 trial focuses on Social Anxiety Disorder and remains completed. Sponsored by Boston University, it has been updated 11 times since 2014, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2023 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Dec 2022 — Jan 2023 [monthly]
Completed EARLY_PHASE1
-
Jan 2021 — Dec 2022 [monthly]
Completed EARLY_PHASE1
▶ Show 6 earlier versions
-
Jul 2020 — Jan 2021 [monthly]
Completed EARLY_PHASE1
-
Nov 2018 — Jul 2020 [monthly]
Completed EARLY_PHASE1
Status: Active Not Recruiting → Completed
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
-
May 2017 — Jun 2018 [monthly]
Recruiting EARLY_PHASE1
-
Feb 2017 — May 2017 [monthly]
Recruiting EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting Phase 0
First recorded
Apr 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston University
- Rush University Medical Center
- Southern Methodist University
- University of Texas at Austin
For direct contact, visit the study record on ClinicalTrials.gov .